Literature DB >> 15861209

Genetics of Crohn disease, an archetypal inflammatory barrier disease.

Stefan Schreiber1, Philip Rosenstiel, Mario Albrecht, Jochen Hampe, Michael Krawczak.   

Abstract

Chronic inflammatory disorders such as Crohn disease, atopic eczema, asthma and psoriasis are triggered by hitherto unknown environmental factors that function on the background of some polygenic susceptibility. Recent technological advances have allowed us to unravel the genetic aetiology of these and other complex diseases. Using Crohn disease as an example, we show how the discovery of susceptibility genes furthers our understanding of the underlying disease mechanisms and how it will, ultimately, give rise to new therapeutic developments. The long-term goal of such endeavours is to develop targeted prophylactic strategies. These will probably target the molecular interaction on the mucosal surface between the products of the genome and the microbial metagenome of a patient.

Entities:  

Mesh:

Year:  2005        PMID: 15861209     DOI: 10.1038/nrg1607

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  87 in total

1.  Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease.

Authors:  Heather Elding; Winston Lau; Dallas M Swallow; Nikolas Maniatis
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

2.  Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype.

Authors:  Philipp Rausch; Ateequr Rehman; Sven Künzel; Robert Häsler; Stephan J Ott; Stefan Schreiber; Philip Rosenstiel; Andre Franke; John F Baines
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-08       Impact factor: 11.205

3.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Authors:  Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

Review 4.  Novel susceptibility genes in inflammatory bowel disease.

Authors:  Colin Noble; Elaine Nimmo; Daniel Gaya; Richard K Russell; Jack Satsangi
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 5.  Plant NBS-LRR proteins in pathogen sensing and host defense.

Authors:  Brody J DeYoung; Roger W Innes
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

6.  Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.

Authors:  Alexandra V Pearce; Sheila A Fisher; Natalie J Prescott; Clive M Onnie; Reenal Pattni; Peter Green; Alastair Forbes; John Mansfield; Jeremy Sanderson; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Int J Colorectal Dis       Date:  2006-05-31       Impact factor: 2.571

7.  No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population.

Authors:  A Franke; A Ruether; N Wedemeyer; T H Karlsen; A Nebel; S Schreiber
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

Review 8.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

9.  Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women.

Authors:  Zhenwu Lin; Lisa Poritz; Andre Franke; Tong-Yi Li; Andreas Ruether; Kathryn A Byrnes; Yunhua Wang; Anthony W Gebhard; Colin MacNeill; Neal J Thomas; Stefan Schreiber; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

10.  Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome.

Authors:  Ipek Akil; Aykan Ozguven; Ebru Canda; Omer Yilmaz; Nalan Nese; Mine Ozkol; Sandra May; Andre Franke; Sebahattin Cirak
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.